13 Oct 2022 , 02:28 PM
The company said the board of directors has approved rights issue size of 7,26,91,239 shares for Rs399.80 crore.
Further, the issue price is Rs55 per share. The rights entitlement ratio is (1:2) one rights equity share for every two shares held by eligible shareholders of the company.
The Record date is October 18, 2022 for the purpose of determining the equity shareholders entitled to receive the rights entitlement in the Rights Issue, the company said.
At around 2:29 PM, Suven Life Sciences Ltd is currently trading at Rs73.90 per share up by Rs3.15 or 4.45% from its previous closing of Rs70.75 per share on the BSE.
For feedback and suggestions, write to us at editorial@iifl.com
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
